ICT01 2588
Alternative Names: EP-0015; ICT 012588; ICT 1&2; ICT01; Smart BombLatest Information Update: 31 Mar 2026
At a glance
- Originator University of Bradford Institute of Cancer Therapeutics
- Developer Incanthera
- Class Antineoplastics; Colchicum alkaloids; Drug conjugates; Peptides
- Mechanism of Action Microtubule protein inhibitors; Tubulin inhibitors; Vascular disrupting agents
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Breast cancer; Colorectal cancer; Lung cancer; Prostate cancer
Most Recent Events
- 31 Mar 2026 Preclinical development is ongoing in Colorectal cancer in UK (Parenteral) (Cancer Research UK pipeline, March 2026)
- 31 Mar 2026 Preclinical development is ongoing in Lung cancer in UK (Parenteral) (Cancer Research UK pipeline, March 2026)
- 31 Mar 2026 Preclinical development is ongoing in Prostate cancer in UK (Parenteral) (Cancer Research UK, March 2026)